Annual SGA
$119.90 M
-$1.77 M-1.45%
December 31, 2023
Summary
- As of February 7, 2025, AGIO annual SGA is $119.90 million, with the most recent change of -$1.77 million (-1.45%) on December 31, 2023.
- During the last 3 years, AGIO annual SGA has risen by +$4.80 million (+4.17%).
- AGIO annual SGA is now -1.45% below its all-time high of $121.67 million, reached on December 31, 2022.
Performance
AGIO SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$38.54 M
+$3.00 M+8.44%
September 30, 2024
Summary
- As of February 7, 2025, AGIO quarterly SGA is $38.54 million, with the most recent change of +$3.00 million (+8.44%) on September 30, 2024.
- Over the past year, AGIO quarterly SGA has increased by +$3.00 million (+8.44%).
- AGIO quarterly SGA is now at all-time high.
Performance
AGIO Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$2.78 B
+$674.31 M+19.52%
September 30, 2024
Summary
- As of February 7, 2025, AGIO TTM SGA is -$2.78 billion, with the most recent change of +$674.31 million (+19.52%) on September 30, 2024.
- Over the past year, AGIO TTM SGA has dropped by -$2.91 billion (-2277.03%).
- AGIO TTM SGA is now -3654.29% below its all-time high of -$74.04 million.
Performance
AGIO TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
AGIO Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.4% | +8.4% | -2277.0% |
| 3 y3 years | +4.2% | +41.9% | -2499.8% |
| 5 y5 years | +5.0% | +16.7% | -2824.9% |
AGIO Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1.4% | at low | at high | +49.2% | -582.3% | +19.5% |
| 5 y | 5-year | -1.4% | +17.5% | at high | +701.7% | -582.3% | +59.1% |
| alltime | all time | -1.4% | +1597.4% | at high | +2379.9% | -3654.3% | +59.1% |
Agios Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $38.54 M(+8.4%) | $140.39 M(+10.0%) |
| Jun 2024 | - | $35.54 M(+14.6%) | $127.68 M(+4.2%) |
| Mar 2024 | - | $31.01 M(-12.2%) | $122.55 M(+2.2%) |
| Dec 2023 | $119.90 M(-1.5%) | $35.30 M(+36.7%) | $119.90 M(+2.2%) |
| Sep 2023 | - | $25.82 M(-15.1%) | $117.37 M(-2.7%) |
| Jun 2023 | - | $30.41 M(+7.2%) | $120.67 M(+1.8%) |
| Mar 2023 | - | $28.37 M(-13.4%) | $118.53 M(-2.6%) |
| Dec 2022 | $121.67 M(+0.2%) | $32.77 M(+12.5%) | $121.67 M(+1.0%) |
| Sep 2022 | - | $29.12 M(+3.0%) | $120.43 M(+1.7%) |
| Jun 2022 | - | $28.26 M(-10.3%) | $118.46 M(-0.8%) |
| Mar 2022 | - | $31.52 M(-0.0%) | $119.41 M(-1.7%) |
| Dec 2021 | $121.44 M(+5.5%) | $31.53 M(+16.1%) | $121.44 M(+4.9%) |
| Sep 2021 | - | $27.15 M(-7.1%) | $115.83 M(-1.0%) |
| Jun 2021 | - | $29.21 M(-12.9%) | $117.02 M(+0.0%) |
| Mar 2021 | - | $33.55 M(+29.5%) | $116.98 M(+1.6%) |
| Dec 2020 | $115.11 M(+12.8%) | $25.91 M(-8.6%) | $115.11 M(+22.4%) |
| Sep 2020 | - | $28.35 M(-2.8%) | $94.00 M(-4.7%) |
| Jun 2020 | - | $29.18 M(-7.9%) | $98.68 M(-3.2%) |
| Mar 2020 | - | $31.67 M(+558.9%) | $101.89 M(-0.1%) |
| Dec 2019 | $102.01 M(-10.6%) | $4.81 M(-85.4%) | $102.01 M(-21.0%) |
| Sep 2019 | - | $33.02 M(+1.9%) | $129.06 M(+1.5%) |
| Jun 2019 | - | $32.39 M(+1.9%) | $127.14 M(+4.7%) |
| Mar 2019 | - | $31.79 M(-0.2%) | $121.39 M(+6.3%) |
| Dec 2018 | $114.14 M | $31.86 M(+2.4%) | $114.14 M(+8.7%) |
| Sep 2018 | - | $31.10 M(+16.8%) | $105.00 M(+14.9%) |
| Jun 2018 | - | $26.63 M(+8.5%) | $91.35 M(+13.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $24.55 M(+8.1%) | $80.85 M(+13.7%) |
| Dec 2017 | $71.12 M(+40.2%) | $22.71 M(+30.1%) | $71.12 M(+11.5%) |
| Sep 2017 | - | $17.46 M(+8.2%) | $63.79 M(+9.6%) |
| Jun 2017 | - | $16.13 M(+8.8%) | $58.19 M(+6.4%) |
| Mar 2017 | - | $14.82 M(-3.6%) | $54.70 M(+7.9%) |
| Dec 2016 | $50.71 M(+40.9%) | $15.38 M(+29.7%) | $50.71 M(+11.4%) |
| Sep 2016 | - | $11.85 M(-6.2%) | $45.52 M(+4.4%) |
| Jun 2016 | - | $12.64 M(+16.7%) | $43.59 M(+9.3%) |
| Mar 2016 | - | $10.84 M(+6.4%) | $39.88 M(+10.8%) |
| Dec 2015 | $35.99 M(+88.2%) | $10.18 M(+2.6%) | $35.99 M(+11.4%) |
| Sep 2015 | - | $9.93 M(+11.2%) | $32.31 M(+17.3%) |
| Jun 2015 | - | $8.93 M(+28.4%) | $27.55 M(+20.9%) |
| Mar 2015 | - | $6.95 M(+7.0%) | $22.79 M(+19.2%) |
| Dec 2014 | $19.12 M(+92.6%) | $6.50 M(+25.8%) | $19.12 M(+17.1%) |
| Sep 2014 | - | $5.17 M(+24.0%) | $16.33 M(+19.2%) |
| Jun 2014 | - | $4.17 M(+26.7%) | $13.69 M(+20.5%) |
| Mar 2014 | - | $3.29 M(-11.3%) | $11.37 M(+14.5%) |
| Dec 2013 | $9.93 M(+40.6%) | $3.71 M(+46.3%) | $9.93 M(+27.7%) |
| Sep 2013 | - | $2.53 M(+38.0%) | $7.78 M(+14.0%) |
| Jun 2013 | - | $1.84 M(-0.9%) | $6.82 M(-1.6%) |
| Mar 2013 | - | $1.85 M(+19.2%) | $6.93 M(-1.8%) |
| Dec 2012 | $7.06 M(-2.1%) | $1.55 M(-1.6%) | $7.06 M(+28.2%) |
| Sep 2012 | - | $1.58 M(-18.9%) | $5.51 M(+40.2%) |
| Jun 2012 | - | $1.95 M(-1.7%) | $3.93 M(+98.3%) |
| Mar 2012 | - | $1.98 M | $1.98 M |
| Dec 2011 | $7.21 M | - | - |
FAQ
- What is Agios Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals annual SGA year-on-year change?
- What is Agios Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly SGA year-on-year change?
- What is Agios Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals TTM SGA year-on-year change?
What is Agios Pharmaceuticals annual SGA?
The current annual SGA of AGIO is $119.90 M
What is the all time high annual SGA for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual SGA is $121.67 M
What is Agios Pharmaceuticals annual SGA year-on-year change?
Over the past year, AGIO annual SGA has changed by -$1.77 M (-1.45%)
What is Agios Pharmaceuticals quarterly SGA?
The current quarterly SGA of AGIO is $38.54 M
What is the all time high quarterly SGA for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly SGA is $38.54 M
What is Agios Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, AGIO quarterly SGA has changed by +$3.00 M (+8.44%)
What is Agios Pharmaceuticals TTM SGA?
The current TTM SGA of AGIO is -$2.78 B
What is the all time high TTM SGA for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high TTM SGA is -$74.04 M
What is Agios Pharmaceuticals TTM SGA year-on-year change?
Over the past year, AGIO TTM SGA has changed by -$2.91 B (-2277.03%)